Metabolomic Profiling of Fecal Samples Reveals Distinct Signatures Associated with Disease Phenotypes and Locations in Crohn’s Disease

Key Points

• The aim is to identify metabolomic differences related to Crohn’s disease phenotypes and activity levels.
• Conducted metabolomic profiling of fecal samples
• Analyzed differences based on disease phenotypes and activity
• Assessed potential as noninvasive biomarkers for patient stratification
• Identified distinct metabolomic signatures tied to disease phenotypes
• Demonstrated variations in metabolomics correlated with disease activity
• Highlighted potential for using metabolites as biomarkers for guiding management